Standardized SEC financial data for Orthofix Medical Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000884624 · NASDAQ · Surgical & Medical Instruments & Apparatus.
Ratios for fiscal year 2025, standardized from SEC filings.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $406.6M | $464.5M | $460.7M | $746.6M | $799.5M | $822.3M |
| Cost of revenue | $101.9M | $114.9M | $123.5M | $260.4M | $253.6M | $256.3M |
| Gross profit | $304.7M | $349.6M | $337.2M | $486.3M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $96.3M | $87.8M | $50.7M | $33.1M | $83.2M | $82.0M |
| Inventory | $84.6M | $83.0M | $100.2M | $222.2M | $189.5M | $172.3M |
| Total current assets | $270.4M | $269.5M | $256.0M | $420.4M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $74.3M | $18.5M | -$11.5M | -$45.8M | $25.8M | $33.3M |
| Capital expenditures | $15.5M | $17.8M | $23.2M | $62.0M | $34.9M | $34.6M |
| Free cash flow | $58.8M | $690K | -$34.7M | -$107.8M |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/OFIX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/OFIX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"| $545.9M |
| $566.0M |
| R&D expense | $39.1M | $49.6M | $49.1M | $80.2M | $73.6M | $65.8M |
| SG&A expense | $204.4M | $221.3M | $308.8M | $530.4M | $532.5M | $554.3M |
| Operating income | -$6.3M | -$8.3M | -$13.3M | -$139.1M | -$84.6M | -$81.4M |
| EBITDA | $24.3M | $21.3M | $15.8M | -$86.0M | -$24.6M | -$4.1M |
| Interest expense | $1.9M | $1.5M | $1.4M | $5.8M | $16.9M | $17.3M |
| Pretax income | -$368K | -$13.5M | -$17.7M | -$148.7M | -$123.9M | -$90.8M |
| Income tax | $2.9M | $24.9M | $2.0M | $2.7M | $2.1M | $1.4M |
| Net income | $2.5M | -$38.4M | -$19.7M | -$151.4M | -$126.0M | -$92.2M |
| EPS (diluted) | $0.13 | $-1.95 | $-0.98 | $-4.12 | $-3.30 | $-2.33 |
Standardized from Orthofix Medical Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
| $433.3M |
| $416.8M |
| Property, plant & equipment | $63.6M | $59.3M | $58.2M | $159.1M | $139.8M | $129.4M |
| Goodwill | $84.0M | $71.3M | $71.3M | $194.9M | $194.9M | $194.9M |
| Total assets | $525.9M | $476.6M | $458.6M | $925.3M | $893.3M | $850.6M |
| Total current liabilities | $103.9M | $105.8M | $83.6M | $165.2M | $168.6M | $170.5M |
| Long-term debt | — | — | — | $94.4M | $157.0M | $157.4M |
| Total debt | — | — | — | $95.6M | $157.0M | $157.4M |
| Total liabilities | $169.0M | $139.7M | $121.8M | $326.6M | $390.2M | $400.6M |
| Retained earnings | $59.4M | $21.0M | $1.3M | -$150.1M | -$276.1M | -$368.3M |
| Total equity | $356.9M | $336.9M | $336.9M | $598.7M | $503.1M | $450.0M |
| -$9.1M |
| -$1.3M |
| Investing cash flow | -$52.3M | -$23.0M | -$24.5M | -$33.1M | -$27.6M | -$34.6M |
| Financing cash flow | $3.2M | -$3.6M | -$78K | $65.3M | $50.7M | -$786K |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 |